1-3 of 3
Authors: István Láng
Journal Article
Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First‐Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor‐Positive/HER2‐Negative Breast Cancer Free
The Oncologist, Volume 19, Issue 4, April 2014, Pages 348–349, https://doi.org/10.1634/theoncologist.2014-0021
Published: 27 March 2014
Journal Article
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer Free
The Oncologist, Volume 19, Issue 4, April 2014, Pages 346–347, https://doi.org/10.1634/theoncologist.2014-0022
Published: 27 March 2014
Journal Article
Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience Free
The Oncologist, Volume 18, Issue 2, February 2013, Pages 134–140, https://doi.org/10.1634/theoncologist.2012-0342
Published: 28 January 2013
